• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童胰岛素抵抗或代谢综合征患者的去脂/去脂体重:系统评价和荟萃分析。

Fat-free/lean body mass in children with insulin resistance or metabolic syndrome: a systematic review and meta-analysis.

机构信息

Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá, DC, Colombia.

Growth, Exercise, Nutrition and Development (GENUD) Research Group, Universidad de Zaragoza, Zaragoza, Spain.

出版信息

BMC Pediatr. 2022 Jan 22;22(1):58. doi: 10.1186/s12887-021-03041-z.

DOI:10.1186/s12887-021-03041-z
PMID:35065638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8783460/
Abstract

BACKGROUND

Lean / Fat Free Body Mass (LBM) is metabolically involved in active processes such as resting energy expenditure, glucose uptake, and myokine secretion. Nonetheless, its association with insulin sensitivity / resistance / glucose tolerance and metabolic syndrome remains unclear in childhood.

METHODS

The current investigation aimed to examine the differences in fat-free mass /lean body mass according to the presence of insulin sensitivity/insulin resistance/glucose tolerance/metabolic syndrome in children. A systematic search was carried out in Medline/PubMed, Embase, Scopus, Web of Science, and SciELO, covering the period from each database's respective start to 21 June 2021. Two researchers evaluated 7111 studies according to the inclusion criteria: original human studies, written in English or Spanish, evaluating fat-free mass/lean body mass in children and adolescents including both with and without insulin sensitivity/insulin resistance /glucose tolerance and metabolic syndrome and reported the differences between them in terms of fat free mass/lean body mass. The results of the studies were combined with insulin sensitivity, insulin, resistance, glucose tolerance and metabolic syndrome. The standardized mean difference (SMD) in each study was calculated and combined using the random-effects model. Heterogeneity between studies was tested using the index of heterogeneity (I), leave-one-out sensitivity analyses were performed, and publication bias was assessed using the Egger and Begg tests.

RESULTS

Finally, 15 studies which compared groups defined according to different glucose homeostasis criteria or metabolic syndrome out of 103 eligible studies were included in this systematic review and 12 studies in the meta-analysis. Meta-analysis showed lower fat-free mass/lean body mass percentage in participants with insulin resistance/glucose tolerance/metabolic syndrome (SMD -0.47; 95% CI, - 0.62 to - 0.32) while in mass units (kg), higher values were found in the same group (SMD, 1.01; 95% CI, 0.43 to 1.60).

CONCLUSIONS

Our results identified lower values of fat-free mass/lean body mass (%) in children and adolescents with insulin resistance/glucose tolerance/metabolic syndrome and higher values of fat-free mass/lean body mass when these are expressed in kg. The evidence of the impact of lean mass on children's glucose homeostasis or metabolic syndrome is limited, so future studies research should focus on explaining the effect of fat-free mass/lean body mass on different metabolic outcomes. Moreover, it may be interesting to evaluate the quality (muscle density) or functional (muscle strength) outcomes in addition to both absolute (kg) and relative (%) values in future studies. The systematic review was prospectively registered at PROSPERO (registration number CRD42019124734; available at: http://www.crd.york.ac.uk/prospero [accessed: 05 April 2019]).

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d9/8783460/b0689786a1fa/12887_2021_3041_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d9/8783460/21b0c188da40/12887_2021_3041_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d9/8783460/8eb81c1e8ef7/12887_2021_3041_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d9/8783460/b0689786a1fa/12887_2021_3041_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d9/8783460/21b0c188da40/12887_2021_3041_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d9/8783460/8eb81c1e8ef7/12887_2021_3041_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77d9/8783460/b0689786a1fa/12887_2021_3041_Fig3_HTML.jpg
摘要

背景

瘦体重(Lean/Fat Free Body Mass,LBM)在代谢方面参与了许多活跃的过程,例如静息能量消耗、葡萄糖摄取和肌因子分泌。尽管如此,其与胰岛素敏感性/抵抗/葡萄糖耐量和代谢综合征之间的关系在儿童中仍不清楚。

方法

本研究旨在探讨儿童中存在胰岛素敏感性/抵抗/葡萄糖耐量/代谢综合征时,无脂体重/瘦体重的差异。对 Medline/PubMed、Embase、Scopus、Web of Science 和 SciELO 中的数据库进行了系统检索,检索时间为每个数据库各自开始至 2021 年 6 月 21 日。两名研究人员根据纳入标准评估了 7111 项研究:原始人类研究,用英语或西班牙语撰写,评估儿童和青少年的无脂体重/瘦体重,包括具有和不具有胰岛素敏感性/抵抗/葡萄糖耐量和代谢综合征的个体,并报告了他们在无脂体重/瘦体重方面的差异。使用随机效应模型计算并结合了每项研究的标准化均数差(SMD)。使用异质性指数(I)检验研究之间的异质性,进行单因素敏感性分析,并使用 Egger 和 Begg 检验评估发表偏倚。

结果

最终,从 103 项合格研究中纳入了 15 项比较不同葡萄糖稳态标准或代谢综合征定义的组别的研究进行系统综述,12 项研究进行了荟萃分析。荟萃分析显示,胰岛素抵抗/葡萄糖耐量/代谢综合征组的无脂体重/瘦体重百分比较低(SMD -0.47;95%CI,-0.62 至-0.32),而在同一组中,无脂体重/瘦体重的单位(kg)值较高(SMD,1.01;95%CI,0.43 至 1.60)。

结论

我们的研究结果发现,患有胰岛素抵抗/葡萄糖耐量/代谢综合征的儿童和青少年的无脂体重/瘦体重百分比较低,而以 kg 表示时,无脂体重/瘦体重的数值较高。关于瘦体重对儿童葡萄糖稳态或代谢综合征的影响的证据有限,因此未来的研究应重点研究无脂体重/瘦体重对不同代谢结果的影响。此外,未来的研究除了绝对(kg)和相对(%)值外,还可以评估无脂体重/瘦体重的质量(肌肉密度)或功能(肌肉力量)结果,这可能很有趣。系统评价已在 PROSPERO(注册号 CRD42019124734;可在:http://www.crd.york.ac.uk/prospero[访问日期:2019 年 4 月 5 日])中进行了前瞻性注册。

相似文献

1
Fat-free/lean body mass in children with insulin resistance or metabolic syndrome: a systematic review and meta-analysis.儿童胰岛素抵抗或代谢综合征患者的去脂/去脂体重:系统评价和荟萃分析。
BMC Pediatr. 2022 Jan 22;22(1):58. doi: 10.1186/s12887-021-03041-z.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.多囊卵巢综合征女性中脂肪与瘦体重比值与代谢功能障碍的关联。
Hum Reprod. 2014 Jul;29(7):1508-17. doi: 10.1093/humrep/deu096. Epub 2014 May 9.
4
Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: A systematic review and meta-analysis of 45 observational studies.肥胖而非高雄激素血症或胰岛素抵抗预测多囊卵巢综合征生殖期妇女的骨骼肌量:45 项观察性研究的系统评价和荟萃分析。
Obes Rev. 2021 Aug;22(8):e13255. doi: 10.1111/obr.13255. Epub 2021 Apr 14.
5
What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?尽管绝经后女性肥胖程度较高,但与正常代谢状况相关的身体特征有哪些?
J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5. doi: 10.1210/jcem.86.3.7365.
6
Impact of saturated compared with unsaturated dietary fat on insulin sensitivity, pancreatic β-cell function and glucose tolerance: a systematic review and meta-analysis of randomized, controlled trials.饱和脂肪与不饱和脂肪对胰岛素敏感性、胰岛β细胞功能和葡萄糖耐量的影响:一项随机对照试验的系统评价和荟萃分析。
Am J Clin Nutr. 2023 Oct;118(4):739-753. doi: 10.1016/j.ajcnut.2023.07.018. Epub 2023 Jul 25.
7
Effect of mind-body exercise on risk factors for metabolic syndrome including insulin resistance: a meta-analysis.身心锻炼对代谢综合征相关风险因素(包括胰岛素抵抗)的影响:一项荟萃分析。
Front Endocrinol (Lausanne). 2024 Jan 26;15:1289254. doi: 10.3389/fendo.2024.1289254. eCollection 2024.
8
Effects of Whey Protein Alone or as Part of a Multi-ingredient Formulation on Strength, Fat-Free Mass, or Lean Body Mass in Resistance-Trained Individuals: A Meta-analysis.乳清蛋白单独或作为多成分配方的一部分对抗阻训练个体的力量、去脂体重或瘦体重的影响:一项荟萃分析。
Sports Med. 2016 Jan;46(1):125-137. doi: 10.1007/s40279-015-0403-y.
9
Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study.出生时小于胎龄且接受生长激素治疗的年轻成人停止生长激素治疗后的代谢健康:一项 5 年纵向研究。
Lancet Diabetes Endocrinol. 2017 Feb;5(2):106-116. doi: 10.1016/S2213-8587(16)30422-3. Epub 2016 Dec 21.
10
Effects of catheter-based renal denervation on glycemic control and lipid levels: a systematic review and meta-analysis.基于导管的肾脏去神经术对血糖控制和血脂水平的影响:系统评价和荟萃分析。
Acta Diabetol. 2021 May;58(5):603-614. doi: 10.1007/s00592-020-01659-6. Epub 2021 Jan 18.

引用本文的文献

1
The role of body composition, cardiometabolic parameters, and resting substrate oxidation in protecting against metabolic syndrome in adolescents with obesity.身体成分、心脏代谢参数和静息底物氧化在预防肥胖青少年代谢综合征中的作用。
Front Nutr. 2025 Jul 30;12:1624696. doi: 10.3389/fnut.2025.1624696. eCollection 2025.
2
Ethnicity modifies the relationship between added sugars and fructose exposure in the first 1000 days and offspring body composition at 24 months.种族会改变前1000天添加糖与果糖摄入量以及24个月时后代身体成分之间的关系。
Nutr Res. 2025 Jul;139:1-15. doi: 10.1016/j.nutres.2025.04.009. Epub 2025 Apr 19.
3

本文引用的文献

1
Visceral Obesity and High Systolic Blood Pressure as the Substrate of Endothelial Dysfunction in Obese Adolescents.内脏肥胖和高收缩压作为肥胖青少年内皮功能障碍的基础
Arq Bras Cardiol. 2021 Apr;116(4):795-803. doi: 10.36660/abc.20190541.
2
[Leptin sexual dimorphism, insulin resistance, and body composition in normal weight prepubescent].正常体重青春期前儿童的瘦素性别差异、胰岛素抵抗和身体组成
Rev Chil Pediatr. 2020 Dec;91(6):924-929. doi: 10.32641/rchped.vi91i6.1403. Epub 2020 Oct 21.
3
Insulin resistance and bone health in adolescents.
Association between lean body mass and osteoarthritis: a cross-sectional study from the NHANES 2007-2018.
瘦体重与骨关节炎之间的关联:一项来自2007 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究。
Sci Rep. 2025 Apr 27;15(1):14726. doi: 10.1038/s41598-025-98795-2.
4
Timing, velocity, and magnitude of pubertal changes in body composition: a longitudinal study.青春期身体成分变化的时间、速度和幅度:一项纵向研究。
Pediatr Res. 2025 Jan;97(1):293-300. doi: 10.1038/s41390-024-03299-w. Epub 2024 Jun 11.
5
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria.苯丙酮尿症患者的身体成分评估和心血管代谢风险的临床标志物。
Nutrients. 2023 Dec 18;15(24):5133. doi: 10.3390/nu15245133.
6
Metabolic complications of obesity in children and adolescents.儿童和青少年肥胖的代谢并发症
Clin Exp Pediatr. 2024 Jul;67(7):347-355. doi: 10.3345/cep.2023.00892. Epub 2023 Nov 16.
7
Anticipated correlation between lean body mass to visceral fat mass ratio and insulin resistance: NHANES 2011-2018.2011 - 2018年美国国家健康与营养检查调查:瘦体重与内脏脂肪量比值与胰岛素抵抗之间的预期相关性
Front Endocrinol (Lausanne). 2023 Sep 13;14:1232896. doi: 10.3389/fendo.2023.1232896. eCollection 2023.
8
Association between lean body mass and hypertension: A cross-sectional study of 50 159 NHANES participants.瘦体重与高血压的关系:对 50159 名 NHANES 参与者的横断面研究。
J Clin Hypertens (Greenwich). 2023 Oct;25(10):957-964. doi: 10.1111/jch.14710. Epub 2023 Aug 23.
9
Changes in the body composition of boys aged 11-18 years due to COVID-19 measures in the Czech Republic.由于捷克共和国 COVID-19 措施的影响,11-18 岁男孩的身体成分发生变化。
BMC Public Health. 2022 Dec 3;22(1):2254. doi: 10.1186/s12889-022-14605-8.
10
Lower fitness levels, higher fat-to-lean mass ratios, and lower cardiorespiratory endurance are more likely to affect the body mass index of Saudi children and adolescents.较低的健康水平、较高的体脂与瘦体重比以及较低的心肺耐力更有可能影响沙特儿童和青少年的体重指数。
Front Public Health. 2022 Oct 6;10:984469. doi: 10.3389/fpubh.2022.984469. eCollection 2022.
青少年的胰岛素抵抗与骨骼健康。
Arch Osteoporos. 2021 Apr 10;16(1):66. doi: 10.1007/s11657-021-00917-6.
4
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
5
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts.世界骨质疏松症、骨关节炎和肌肉骨骼疾病大会(2020年世界骨质疏松症基金会-欧洲抗风湿联盟-国际骨质疏松基金会大会):海报摘要
Osteoporos Int. 2020 Dec;31(Suppl 1):133-621. doi: 10.1007/s00198-020-05696-3.
6
Relationship between insulin-like growth factor-1, insulin resistance and metabolic profile with pre-obesity and obesity in children.儿童期肥胖前期和肥胖与胰岛素样生长因子-1、胰岛素抵抗和代谢特征的关系。
J Pediatr Endocrinol Metab. 2021 Feb 23;34(3):301-309. doi: 10.1515/jpem-2020-0447. Print 2021 Mar 26.
7
Fat Mass Accretion from Birth to 5 Years and Metabolic Homeostasis in Childhood: the Healthy Start Study.从出生到 5 岁的脂肪量增加与儿童期的代谢稳态:健康开始研究。
J Clin Endocrinol Metab. 2021 May 13;106(6):1684-1691. doi: 10.1210/clinem/dgab115.
8
Metabolic flexibility across the spectrum of glycemic regulation in youth.青年人群血糖调节范围内的代谢灵活性。
JCI Insight. 2021 Feb 22;6(4):146000. doi: 10.1172/jci.insight.146000.
9
Cardiometabolic efficacy of multidisciplinary weight loss interventions is not altered in adolescents with obesity initially diagnosed or with a persistent metabolic syndrome.多学科减重干预对肥胖青少年和持续性代谢综合征青少年的心脏代谢效果没有改变。
Nutr Res. 2021 Feb;86:79-87. doi: 10.1016/j.nutres.2020.12.008. Epub 2020 Dec 5.
10
The effect of different adiposity factors on insulin resistance in obese children and adolescents.不同肥胖因素对肥胖儿童和青少年胰岛素抵抗的影响。
Clin Endocrinol (Oxf). 2021 Jun;94(6):949-955. doi: 10.1111/cen.14435. Epub 2021 Apr 20.